Luciano Costa/LinkedIn
Jul 13, 2025, 00:47
Luciano J Costa: Most Innovation in Multiple Myeloma is from China
Luciano J Costa, Professor at University of Alabama at Birmingham, shared a post on X:
“Among 25 multiple myeloma phase 1 trials posted in CT.gov in last 6 months, only 5 have US sites. Most innovation is from China. I just learned of two very promising approaches/drugs that completely abandoned US development. Cost of our red tape, FDA instability, moving goalposts. Successful drugs will be back 4 Ph3 , so long we remain the richest market. Our patients are being excluded from innovation, our population not represented in the studies, defeating the FDA’s own intent… frustrating.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 13, 2025, 03:48
Jul 13, 2025, 00:47
Jul 12, 2025, 23:29
Jul 12, 2025, 23:19
Jul 12, 2025, 20:03
Jul 12, 2025, 18:58